[Treatment with estramustine phosphate in advanced prostatic cancer].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology; D000368:Aged; D002219:Carbamates / Q000627:therapeutic use; D004962:Estranes / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010166:Palliative Care; D010756:Phosphoric Acids / Q000627:therapeutic use; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology
D002219:Carbamates; D004962:Estranes; D009588:Nitrogen Mustard Compounds; D010756:Phosphoric Acids; D010744:Phosphoric Monoester Hydrolases
Behandlung mit Estramustinphosphat bei fortgeschrittenen Prostatakarzinomen.